Matthew P Deek

8PUBLICATIONS
55CO-AUTHORS
Radiation therapyPredictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Jul 18, 2024
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer.

Philip Sutera, Jongmyung Kim, Ritesh Kumar

|Sep 25, 2023
Metastasis-Directed Therapy: A Moving Target Advancing Progress Forward.

Matthew P Deek, Phuoc T Tran, Salma K Jabbour

|Feb 23, 2023
Waiting for Big Changes in Limited-Stage Small-Cell Lung Cancer: For Now, More of the Same.

Matthew P Deek, Missak Haigentz, Salma K Jabbour

|Nov 11, 2022
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.

Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai

|Aug 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.

Matthew P Deek, Kim Van der Eecken, Philip Sutera

Pageof 2

Frequent Collaborators

5 joint publications

Phuoc T Tran

4 joint publications

Channing J Paller

4 joint publications

Curtiland Deville

3 joint publications

Emmanuel S Antonarakis